Mayne Pharma Commercial Revenue, Growth & Competitor Profile

DBA MAYNE PHARMA
DBA METRICS, INC.

Company Profile & Annual Report for Mayne Pharma Commercial

Access the complete profile.

Mayne Pharma Commercial Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 54171 Research & Development in the Physical, Engineering & Life Sciences
Address	3301 Benson Dr. Suite 401 Raleigh, NC 27609

Note: Revenues for privately held companies are statistical evaluations.


Mayne Pharma Commercial's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Mayne Pharma Commercial's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Mayne Pharma Commercial is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Mayne Pharma Commercial Annual Revenue and Growth Rate

Mayne Pharma Commercial	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Mayne Pharma Commercial's revenues are gauged from an analysis of company filings.

Mayne Pharma Commercial's Income Statement (based on Industry Averages)

Mayne Pharma Commercial P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Mayne Pharma Commercial is developing and marketing. Mayne Pharma Commercial doesn't have any recent trademark applications, indicating Mayne Pharma Commercial is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
JEWELLA Oral contraceptives	07/13/2021
NYMYO Oral contraceptives	08/05/2020
OLYVA Oral contraceptives	08/05/2020

See all trademarks and details in the Full Report.

Market Share of Mayne Pharma Commercial's Largest Competitors

A competitive analysis shows these companies are in the same general field as Mayne Pharma Commercial, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Mayne Pharma Commercial. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FALLS OF NEUSE MANAGMENT LLC A NORTH CAROLINA	Raleigh, NC	100
UMICORE USA	Raleigh, NC	25
MAYNE PHARMA COMMERCIAL	Raleigh, NC	22
REDHILL BIOPHARMA	Raleigh, NC	2
VERONA PHARMA	Raleigh, NC	1
GREENWICH BAY TRADING	Raleigh, NC	1
NSI SOLUTIONS	Raleigh, NC	1
PLANT HEALTH CARE	Raleigh, NC	1
B3 SYSTEMS OF DELAWARE	Raleigh, NC	0

Future Competition: Mayne Pharma Commercial's Fastest Growing Competitors

These companies are in the same general field as Mayne Pharma Commercial and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)